Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CCNB2 | O95067 | 12/20 | 0.41 |
| ▸ | CDK1 | P06493 | 12/20 | 0.41 |
| ▸ | CCNB1 | P14635 | 12/20 | 0.41 |
| ▸ | CCNB3 | Q8WWL7 | 12/20 | 0.41 |
| ▸ | GSK3B | P49841 | 11/20 | 0.41 |
| ▸ | CDK5 | Q00535 | 10/20 | 0.41 |
| ▸ | CDK5R1 | Q15078 | 10/20 | 0.41 |
| ▸ | GSK3A | P49840 | 7/20 | 0.41 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.39 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.39 |
| ▸ | HCAR1 | Q9BXC0 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29623547 | 1.00 | MAPK1 (0.46) | MAPK1CCNB2CDK1CCNB1CCNB3 | |
| SCHEMBL30498462 | 0.72 | HCAR1 (0.35) | HCAR1 | |
| SCHEMBL6796288 | 0.72 | HCAR1 (0.35) | HCAR1 | |
| SCHEMBL217245 | 0.72 | AURKA (0.43) | CCNB2CDK1CCNB1CCNB3GSK3B | |
| Hydrochloric Acid SCHEMBL8793075 | 0.71 | AURKA (0.42) | CCNB2CDK1CCNB1CCNB3GSK3B | |
| Hydrochloric Acid SCHEMBL29397868 | 0.71 | AURKA (0.42) | CCNB2CDK1CCNB1CCNB3GSK3B | |
| SCHEMBL14901140 | 0.71 | MAPK1 (0.43) | MAPK1CDK5PDE3BPDE3AHCAR1 | |
| SCHEMBL586351 | 0.70 | DAO (0.53) | PDE3BPDE3AHCAR1 | |
| SCHEMBL126973 | 0.70 | DAO (0.53) | PDE3BPDE3A | |
| SCHEMBL31042178 | 0.70 | DAO (0.53) | PDE3BPDE3AHCAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026088070-A1 | COMPOUNDS | PFIZER INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-4587014-A2 | C5AR1 ANTAGONISTS AND USES THEREOF | Vanqua Bio, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| WO-2024059096-A2 | C5AR1 ANTAGONISTS AND USES THEREOF | VANQUA BIO, INC. (US) | 2024-03-21 | — | — | WO | disclosed |
| US-20230136702-A1 | Inhibitors of Human Herpesviruses | THE GOVERNORS OF THE UNIVERSTIY OF ALBERTA (CA) | 2023-05-04 | — | — | US | disclosed |
| CN-115433211-A | Pyrazidopyridone methionine adenosyltransferase 2A inhibitors | 南京正大天晴制药有限公司 | 2022-12-06 | — | — | CN | disclosed |
| CN-108137616-B | Antibacterial agents comprising pyrazino [2,3-b ] [1,4] oxazin-3-ones or related ring systems | 葛兰素史克知识产权开发有限公司 | 2020-06-26 | — | — | CN | disclosed |
| US-8507488-B2 | Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors | IRM LLC (BM) | 2013-08-13 | — | — | US | disclosed |
| EP-2611815-A1 | HERBICIDE-EFFECTIVE PYRIDYL KETOSULTAMS | Bayer Intellectual Property GmbH (DE) | 2013-07-10 | — | — | EP | disclosed |
| US-20120065065-A1 | HERBICIDALLY ACTIVE PYRIDYLKETOSULTAMS | BAYER CROPSCIENCE AG (DE) | 2012-03-15 | — | — | US | disclosed |
| WO-2012028580-A1 | HERBICIDE-EFFECTIVE PYRIDYL KETOSULTAMS | BAYER CROPSCIENCE AG (DE) | 2012-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230136702-A1 | Inhibitors of Human Herpesviruses | RPL5, RPL35, HAVCR2 | MAPK1 2872/4885CCNB2 1066/4885CDK1 257/4885 |
| US-20120065065-A1 | HERBICIDALLY ACTIVE PYRIDYLKETOSULTAMS | PDXK, CBR3, CBR1 | MAPK1 1016/4885CCNB2 1286/4885CDK1 452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.